Skip to main content

Advertisement

SpringerLink
Log in

Successful Cetuximab Therapy After Failure of Panitumumab Rechallenge in a Patient with Metastatic Colorectal Cancer: Restoration of Drug Sensitivity After Anti-EGFR Monoclonal Antibody-Free Interval

  • Letter to the Editor
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Hata A, Katakami N, Fujita S, et al. Panitumumab rechallenge in chemorefractory patients with metastatic colorectal cancer. J Gastrointest Cancer. 2013;44:456–9.

    Article  PubMed  Google Scholar 

  2. Santini D, Vincenzi B, Addeo R, et al. Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? Ann Oncol. 2012;23:2313–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosure

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

  1. Division of Integrated Oncology, Institute of Biomedical Research and Innovation, 2-2, Minatojima-minamimachi, Chuo-ku, Kobe, 650-0047, Japan

    Akito Hata & Nobuyuki Katakami

  2. Department of Internal Medicine, Kasai City Hospital, Kasai, Japan

    Naoto Kitajima

Authors
  1. Akito Hata
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nobuyuki Katakami
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Naoto Kitajima
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Akito Hata.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hata, A., Katakami, N. & Kitajima, N. Successful Cetuximab Therapy After Failure of Panitumumab Rechallenge in a Patient with Metastatic Colorectal Cancer: Restoration of Drug Sensitivity After Anti-EGFR Monoclonal Antibody-Free Interval. J Gastrointest Canc 45, 506–507 (2014). https://doi.org/10.1007/s12029-014-9624-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-014-9624-9

Keywords

Search

Navigation